SCHEMBL4036196

SCHEMBL4036196

COc1ccc2c(c1)NC(c1cccc(Cl)c1)(C(C(=O)NC1CCCCC1)C1CCCCC1)N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.43
NR1H4 Q96RI1 1/20 0.42
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 2/20 0.39
EPHX2 P34913 2/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
NFKB1 P19838 1/20 0.39
CASP3 P42574 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044495 1.00 GRM5 (0.43) GRM5NR1H4NPC1RAB9ASMN1; SMN2
SCHEMBL4039126 1.00 GRM5 (0.43) GRM5NR1H4NPC1RAB9ASMN1; SMN2
SCHEMBL4039906 0.99 GRM5 (0.44) GRM5NR1H4NPC1RAB9ASMN1; SMN2
SCHEMBL4045000 0.90 NR1H4 (0.48) NR1H4NPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL4038480 0.90 NR1H4 (0.48) NR1H4NPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL4037444 0.90 NR1H4 (0.48) NR1H4NPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL4035053 0.88 LMNA (0.44) NR1H4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4041511 0.88 LMNA (0.44) NR1H4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4038748 0.88 LMNA (0.44) NR1H4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4044980 0.87 LMNA (0.43) NR1H4NPC1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed